Current Knowledge of the Platelet Glycoprotein IIb/IIIa Receptor Antagonists for the Treatment of Coronary Artery Disease

Publisher： Karger

E-ISSN： 1424-8840|30|3|27-43

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.30, Iss.3, 2004-11, pp. : 27-43

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Characteristics, Treatment and Outcome of Patients with Non-ST-Elevation Acute Coronary Syndromes and Multivessel Coronary Artery Disease: Observations from PURSUIT (Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrelin Therapy)

By  

Cardiology, Vol. 98, Iss. 4, 2003-01 ,pp. : 195-201

Karger

Access to resources Recommend Favorite

A randomized trial assessing the impact of three different glycoprotein IIb/IIIa antagonists on glycoprotein IIb/IIIa platelet receptor inhibition and clinical endpoints in patients with acute coronary syndromes

By  

CARDIOVASCULAR THERAPEUTICS (ELECTRONIC), Vol. 34, Iss. 5, 2016-10 ,pp. : 330-336

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Quick Simple Method of Determining Platelet Aggregability following Glycoprotein IIb/IIIa Receptor Inhibitor Administration

By  

Cardiology, Vol. 91, Iss. 3, 1999-09 ,pp. : 156-160

Karger

Access to resources Recommend Favorite

Effects of Glycoprotein IIb/IIIa Receptor Inhibition with Tirofiban on Minor Myocardial Damage in Angiographically Successful Percutaneous Coronary Angioplasty

By  

Cardiology, Vol. 102, Iss. 1, 2004-04 ,pp. : 18-23

Karger

Access to resources Recommend Favorite

The emerging role of platelet glycoprotein IIb/IIIa inhibitors in managing high-risk patients with non-ST segment elevation acute coronary syndromes

By Bolognese Leonardo  

Current Medical Research and Opinion, Vol. 23, Iss. 6, 2007-06 ,pp. : 1217-1226

Informa Healthcare

Access to resources Recommend Favorite